Entering text into the input field will update the search result below

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q4 2020 Results - Earnings Call Transcript

Mar. 04, 2021 7:48 PM ETFulgent Genetics, Inc. (FLGT)1 Comment
SA Transcripts profile picture
SA Transcripts

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2020 Results Conference Call March 4, 2021 4:30 PM ET

Company Participants

Nicole Borsje - Head of Investor Relations

Ming Hsieh - Chief Executive Officer

Brandon Perthuis - Chief Commercial Officer

Paul Kim - Chief Financial Officer

Conference Call Participants

Steven Mah - Piper Sandler

Erin Wright - Credit Suisse

Sung Ji Nam - BTIG


Ladies and gentlemen, thank you for standing by, and welcome to the Fulgent Genetics Fourth Quarter 2020 Earnings Conference Call. At this time, all participant lines are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded. [Operator Instructions].

I would now like to hand the conference to your speaker today, Nicole Borsje. Please go ahead, ma'am.

Nicole Borsje

Great. Thanks very much. Good afternoon, and welcome to the Fulgent Genetics fourth quarter and full year 2020 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, the company's Chief Commercial Officer. The company's press release discussing its financial results is available in the Investor Relations section of the company's website, fulgentgenetics.com. An audio replay of this call will be available shortly after the call concludes. Please visit the Investor Relations section of the company's website to access the audio replay.

Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. These forward-looking statements represent management's estimates based on current use and assumptions, which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties and changes in circumstances that may cause actual results to differ from those described in the forward-looking statements.

The company assumes no obligation to

Recommended For You

Comments (1)

etrade2000 profile picture
"We are a technology platform company with the ability to excel in many areas of health care. We are a team of engineers, geneticists, genetic counselors and business operators with a fierce motivation to make Fulgent a dominant force. We have proven with our platform and infrastructure that we can run a laboratory that far outpaces many genomic labs in terms of efficiency and scalability..."

Yes! This is what I'm looking for in a company. They have successfully transformed themselves into a technology platform company that can execute and deliver results. Software is what enables them to do 100K tests per day with 24 hour turnaround. That is unheard of in the industry. Ming mentioned that they're looking to expand internationally and also look at M&A opportunities. I'm pumped!!!
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.